15 Nov IU-affiliated biotechnology startup will use seed funding toward mission of developing new treatments for HPV-related cancer
FOR IMMEDIATE RELEASE Nov. 15, 2021 INDIANAPOLIS -- With the support of IU Ventures and the IU Innovation and Commercialization Office, Kovina Therapeutics, a preclinical biotechnology startup seeking to develop new treatments for Human Papillomavirus-related infections and cancers, recently closed a $2 million seed round of financing....